Ionis Pharmaceuticals (IONS) Misses Q2 EPS by 13c

Ionis Pharmaceuticals (NASDAQ: IONS) reported Q2 EPS of ($0.74), $0.13 worse than the analyst estimate of ($0.61). Revenue for the quarter came in at $134 million versus the consensus estimate of $140.73 million.

For earnings history and earnings-related data on Ionis Pharmaceuticals (IONS) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance